Premenstrual Syndrome Market 2027 by Treatment Type | The Insight Partners

Premenstrual Syndrome Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by : Treatment Type (Painkillers, Oral contraceptive pills, Estrogen-only patches and implants, Gonadotropin-releasing hormone (GnRH) analogues, Selective serotonin reuptake inhibitors (SSRIs))

Report Code: TIPRE00008488 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Premenstrual syndrome (PMS) alternatively known as premenstrual tension is a combination of physical, emotional, psychological disturbances among women of child bearing age. Premenstrual syndrome symptom occurs 1-2 weeks before the onset of menstruation and usually disappears once the menstrual bleeding starts. The exact cause of the disease is though not clear yet fluctuations in hormone level are one of the prominent reasons for onset of symptoms.


MARKET DYNAMICS

The premenstrual syndrome market is anticipated to grow owing to increasing awareness among young women about premenstrual syndrome especially in developed economies. However, rising awareness due to several government and non-government campaigns is expected to boost the sale of the medical drugs used to treat PMS. Moreover, easy availability of OTC PMS treatment drugs, the access to treatments have become easier, thus further supporting the market growth

MARKET SCOPE

The "Premenstrual Syndrome Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of in premenstrual syndrome market with detailed market segmentation by treatment type and geography. The premenstrual syndrome market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in premenstrual syndrome market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The premenstrual syndrome market is segmented on the basis of treatment type. Based on treatment type the market is segmented as painkillers, oral contraceptive pills, estrogen-only patches and implants, gonadotropin-releasing hormone (GnRH) analogues and selective serotonin reuptake inhibitors (SSRIs).

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in premenstrual syndrome market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The premenstrual syndrome market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting premenstrual syndrome market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the premenstrual syndrome market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in premenstrual syndrome market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in premenstrual syndrome market are anticipated to have lucrative growth opportunities in the future with the rising demand for in premenstrual syndrome market in the global market. Below mentioned is the list of few companies engaged in the premenstrual syndrome market.

The report also includes the profiles of key in premenstrual syndrome market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Alva-Amco Pharmacal Cos., Inc
- Bayer, Inc.
- Bristol-Myers Squibb Company
- Chattem, Inc. (Sanofi)
- DEKK-TEC, Inc.
- GlaxoSmithKline Plc
- MetP Pharma AG
- Novartis AG
- Pherin Pharmaceuticals, Inc.
- Umecrine Mood AB

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Premenstrual Syndrome Market - By Treatment Type
1.3.2 Premenstrual Syndrome Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PREMENSTRUAL SYNDROME MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PREMENSTRUAL SYNDROME MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. PREMENSTRUAL SYNDROME MARKET - GLOBAL MARKET ANALYSIS
6.1. PREMENSTRUAL SYNDROME - GLOBAL MARKET OVERVIEW
6.2. PREMENSTRUAL SYNDROME - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PREMENSTRUAL SYNDROME MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT TYPE
7.1. OVERVIEW
7.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
7.3. PAINKILLERS
7.3.1. Overview
7.3.2. Painkillers Market Forecast and Analysis
7.4. ORAL CONTRACEPTIVE PILLS
7.4.1. Overview
7.4.2. Oral contraceptive pills Market Forecast and Analysis
7.5. ESTROGEN-ONLY PATCHES AND IMPLANTS
7.5.1. Overview
7.5.2. Estrogen-only patches and implants Market Forecast and Analysis
7.6. GONADOTROPIN-RELEASING HORMONE (GNRH) ANALOGUES
7.6.1. Overview
7.6.2. Gonadotropin-releasing hormone (GnRH) analogues Market Forecast and Analysis
7.7. SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS)
7.7.1. Overview
7.7.2. Selective serotonin reuptake inhibitors (SSRIs) Market Forecast and Analysis
8. PREMENSTRUAL SYNDROME MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Premenstrual Syndrome Market Overview
8.1.2 North America Premenstrual Syndrome Market Forecasts and Analysis
8.1.3 North America Premenstrual Syndrome Market Forecasts and Analysis - By Treatment Type
8.1.4 North America Premenstrual Syndrome Market Forecasts and Analysis - By Countries
8.1.4.1 United States Premenstrual Syndrome Market
8.1.4.1.1 United States Premenstrual Syndrome Market by Treatment Type
8.1.4.2 Canada Premenstrual Syndrome Market
8.1.4.2.1 Canada Premenstrual Syndrome Market by Treatment Type
8.1.4.3 Mexico Premenstrual Syndrome Market
8.1.4.3.1 Mexico Premenstrual Syndrome Market by Treatment Type
8.2. EUROPE
8.2.1 Europe Premenstrual Syndrome Market Overview
8.2.2 Europe Premenstrual Syndrome Market Forecasts and Analysis
8.2.3 Europe Premenstrual Syndrome Market Forecasts and Analysis - By Treatment Type
8.2.4 Europe Premenstrual Syndrome Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Premenstrual Syndrome Market
8.2.4.1.1 Germany Premenstrual Syndrome Market by Treatment Type
8.2.4.2 France Premenstrual Syndrome Market
8.2.4.2.1 France Premenstrual Syndrome Market by Treatment Type
8.2.4.3 Italy Premenstrual Syndrome Market
8.2.4.3.1 Italy Premenstrual Syndrome Market by Treatment Type
8.2.4.4 Spain Premenstrual Syndrome Market
8.2.4.4.1 Spain Premenstrual Syndrome Market by Treatment Type
8.2.4.5 United Kingdom Premenstrual Syndrome Market
8.2.4.5.1 United Kingdom Premenstrual Syndrome Market by Treatment Type
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Premenstrual Syndrome Market Overview
8.3.2 Asia-Pacific Premenstrual Syndrome Market Forecasts and Analysis
8.3.3 Asia-Pacific Premenstrual Syndrome Market Forecasts and Analysis - By Treatment Type
8.3.4 Asia-Pacific Premenstrual Syndrome Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Premenstrual Syndrome Market
8.3.4.1.1 Australia Premenstrual Syndrome Market by Treatment Type
8.3.4.2 China Premenstrual Syndrome Market
8.3.4.2.1 China Premenstrual Syndrome Market by Treatment Type
8.3.4.3 India Premenstrual Syndrome Market
8.3.4.3.1 India Premenstrual Syndrome Market by Treatment Type
8.3.4.4 Japan Premenstrual Syndrome Market
8.3.4.4.1 Japan Premenstrual Syndrome Market by Treatment Type
8.3.4.5 South Korea Premenstrual Syndrome Market
8.3.4.5.1 South Korea Premenstrual Syndrome Market by Treatment Type
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Premenstrual Syndrome Market Overview
8.4.2 Middle East and Africa Premenstrual Syndrome Market Forecasts and Analysis
8.4.3 Middle East and Africa Premenstrual Syndrome Market Forecasts and Analysis - By Treatment Type
8.4.4 Middle East and Africa Premenstrual Syndrome Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Premenstrual Syndrome Market
8.4.4.1.1 South Africa Premenstrual Syndrome Market by Treatment Type
8.4.4.2 Saudi Arabia Premenstrual Syndrome Market
8.4.4.2.1 Saudi Arabia Premenstrual Syndrome Market by Treatment Type
8.4.4.3 U.A.E Premenstrual Syndrome Market
8.4.4.3.1 U.A.E Premenstrual Syndrome Market by Treatment Type
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Premenstrual Syndrome Market Overview
8.5.2 South and Central America Premenstrual Syndrome Market Forecasts and Analysis
8.5.3 South and Central America Premenstrual Syndrome Market Forecasts and Analysis - By Treatment Type
8.5.4 South and Central America Premenstrual Syndrome Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Premenstrual Syndrome Market
8.5.4.1.1 Brazil Premenstrual Syndrome Market by Treatment Type
8.5.4.2 Argentina Premenstrual Syndrome Market
8.5.4.2.1 Argentina Premenstrual Syndrome Market by Treatment Type
9. INDUSTRY LANDSCAPE
9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
10. PREMENSTRUAL SYNDROME MARKET, KEY COMPANY PROFILES
10.1. ALVA-AMCO PHARMACAL COS., INC
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. BAYER, INC.
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. BRISTOL-MYERS SQUIBB COMPANY
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. CHATTEM, INC. (SANOFI)
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. DEKK-TEC, INC.
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. GLAXOSMITHKLINE PLC
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. METP PHARMA AG
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. NOVARTIS AG
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. PHERIN PHARMACEUTICALS, INC.
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
10.10. UMECRINE MOOD AB
10.10.1. Key Facts
10.10.2. Business Description
10.10.3. Products and Services
10.10.4. Financial Overview
10.10.5. SWOT Analysis
10.10.6. Key Developments
11. APPENDIX
11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS
The List of Companies

1. Alva-Amco Pharmacal Cos., Inc
2. Bayer, Inc.
3. Bristol-Myers Squibb Company
4. Chattem, Inc. (Sanofi)
5. DEKK-TEC, Inc.
6. GlaxoSmithKline Plc
7. MetP Pharma AG
8. Novartis AG
9. Pherin Pharmaceuticals, Inc.
10. Umecrine Mood AB
TIPRE00008488
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking